{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:58:22Z","timestamp":1761541102956,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.vascn.2012.11.003","type":"journal-article","created":{"date-parts":[[2012,12,8]],"date-time":"2012-12-08T16:15:55Z","timestamp":1354983355000},"page":"91-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Troubleshooting the rabbit ferric chloride-induced arterial model of thrombosis to assess in vivo efficacy of antithrombotic drugs"],"prefix":"10.1016","volume":"67","author":[{"given":"L.","family":"Couture","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.P.","family":"Richer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"H\u00e9lie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Lehoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.M.","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vascn.2012.11.003_bb0005","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/01.fjc.0000141475.14007.ab","article-title":"In vitro and in vivo antithrombotic activity of PD-198961, a novel synthetic factor Xa Inhibitor","volume":"44","author":"Chi","year":"2004","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"3","key":"10.1016\/j.vascn.2012.11.003_bb0010","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.vascn.2011.09.001","article-title":"An optimized method to assess in vivo efficacy of antithrombotic drugs using optical coherence tomography and a modified Doppler flow system","volume":"64","author":"Couture","year":"2011","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"4","key":"10.1016\/j.vascn.2012.11.003_bb0015","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1538-7836.2011.04218.x","article-title":"Mechanisms underlying FeCl3-induced arterial thrombosis","volume":"9","author":"Eckly","year":"2011","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"2","key":"10.1016\/j.vascn.2012.11.003_bb0020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bcmd.2005.12.018","article-title":"Cancer-associated thrombosis","volume":"36","author":"Furie","year":"2006","journal-title":"Blood Cells, Molecules & Diseases"},{"issue":"9","key":"10.1016\/j.vascn.2012.11.003_bb0025","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1111\/j.1538-7836.2008.03064.x","article-title":"DU-176b, a potent and orally active factor Xa inhibitor: In vitro and in vivo pharmacological profiles","volume":"6","author":"Furugohri","year":"2008","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"7","key":"10.1016\/j.vascn.2012.11.003_bb0040","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nri1882","article-title":"The immune response in atherosclerosis: A double-edged sword","volume":"6","author":"Hansson","year":"2006","journal-title":"Nature Reviews Immunology"},{"issue":"1","key":"10.1016\/j.vascn.2012.11.003_bb0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0049-3848(95)00155-K","article-title":"Species differences in anticoagulant and anti-Xa activity of DX-9065a, a highly selective factor Xa inhibitor","volume":"80","author":"Hara","year":"1995","journal-title":"Thrombosis Research"},{"issue":"2","key":"10.1016\/j.vascn.2012.11.003_bb0035","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1055\/s-0038-1649790","article-title":"DX-9065a, an orally active, specific inhibitor of factor Xa, inhibits thrombosis without affecting bleeding time in rats","volume":"74","author":"Hara","year":"1995","journal-title":"Thrombosis and Haemostasis"},{"issue":"2\u20133","key":"10.1016\/j.vascn.2012.11.003_bb0045","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0014-2999(99)00902-4","article-title":"Antithrombotic efficacy of RPR208566, a novel factor Xa inhibitor, in a rat model of carotid artery thrombosis","volume":"389","author":"Heran","year":"2000","journal-title":"European Journal of Pharmacology"},{"issue":"1","key":"10.1016\/j.vascn.2012.11.003_bb0050","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1055\/s-2008-1047567","article-title":"The future of anticoagulation","volume":"29","author":"Hoppensteadt","year":"2008","journal-title":"Seminars in Respiratory and Critical Care Medicine"},{"issue":"4","key":"10.1016\/j.vascn.2012.11.003_bb0055","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0049-3848(90)90106-M","article-title":"Rat model of arterial thrombosis induced by ferric chloride","volume":"60","author":"Kurz","year":"1990","journal-title":"Thrombosis Research"},{"issue":"2","key":"10.1016\/j.vascn.2012.11.003_bb0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1056-8719(00)00095-2","article-title":"Contribution of in vivo models of thrombosis to the discovery and development of novel antithrombotic agents","volume":"43","author":"Leadley","year":"2000","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"8","key":"10.1016\/j.vascn.2012.11.003_bb0065","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1055\/s-0029-1145256","article-title":"Sepsis, coagulation, and antithrombin: Old lessons and new insights","volume":"34","author":"Levi","year":"2008","journal-title":"Seminars in Thrombosis and Hemostasis"},{"issue":"25","key":"10.1016\/j.vascn.2012.11.003_bb0070","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1161\/CIRCULATIONAHA.105.537878","article-title":"Pathophysiology of coronary artery disease","volume":"111","author":"Libby","year":"2005","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.vascn.2012.11.003_bb0075","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1055\/s-0037-1614962","article-title":"Assessment of thrombin inhibitor efficacy in a novel rabbit model of simultaneous arterial and venous thrombosis","volume":"79","author":"Marsh Lyle","year":"1998","journal-title":"Thrombosis and Haemostasis"},{"issue":"6","key":"10.1016\/j.vascn.2012.11.003_bb0080","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/hrt.2007.117382","article-title":"In vivo optical coherence tomography of experimental thrombosis in a rabbit carotid model","volume":"94","author":"Meng","year":"2008","journal-title":"Heart"},{"issue":"3 Suppl.","key":"10.1016\/j.vascn.2012.11.003_bb0085","doi-asserted-by":"crossref","first-page":"33S","DOI":"10.1378\/chest.124.3_suppl.33S","article-title":"Thrombin and fibrinolysis","volume":"124","author":"Nesheim","year":"2003","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.vascn.2012.11.003_bb0090","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1538-7836.2005.01166.x","article-title":"In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939-an oral, direct factor Xa inhibitor","volume":"3","author":"Perzborn","year":"2005","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"Suppl. 1","key":"10.1016\/j.vascn.2012.11.003_bb0095","first-page":"49S","article-title":"Acute arterial thrombosis in rabbits: Reduced platelet accumulation after treatment with dazoxiben hydrochloride (UK 37,248-01)","volume":"15","author":"Randall","year":"1983","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1016\/j.vascn.2012.11.003_bb0100","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1161\/01.CIR.85.2.805","article-title":"Conjunctive enhancement of enzymatic thrombolysis and prevention of thrombotic reocclusion with the selective factor Xa inhibitor, tick anticoagulant peptide. Comparison to hirudin and heparin in a canine model of acute coronary artery thrombosis","volume":"85","author":"Sitko","year":"1992","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.vascn.2012.11.003_bb0105","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.vascn.2009.11.002","article-title":"Optimization of ferric chloride induced thrombosis model in rats: Effect of anti-platelet and anti-coagulant drugs","volume":"61","author":"Surin","year":"2010","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"2","key":"10.1016\/j.vascn.2012.11.003_bb0110","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.thromres.2005.09.004","article-title":"Transendothelial migration of ferric ion in FeCl3 injured murine common carotid artery","volume":"118","author":"Tseng","year":"2006","journal-title":"Thrombosis Research"},{"issue":"1\u20132","key":"10.1016\/j.vascn.2012.11.003_bb0115","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.thromres.2004.07.009","article-title":"An optimized murine model of ferric chloride-induced arterial thrombosis for thrombosis research","volume":"115","author":"Wang","year":"2005","journal-title":"Thrombosis Research"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871912003000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871912003000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T23:57:25Z","timestamp":1761004645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871912003000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1056871912003000"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2012.11.003","relation":{},"ISSN":["1056-8719"],"issn-type":[{"type":"print","value":"1056-8719"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Troubleshooting the rabbit ferric chloride-induced arterial model of thrombosis to assess in vivo efficacy of antithrombotic drugs","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2012.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2012 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}